Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Deafness, Dizziness, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Vestibular Diseases, Hearing Loss

NCT05641441 2025-01-13

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

Recruiting

258 enrolled

CNS

Ototoxicity, Neuroma, Acoustic, Hearing Loss

NCT06490029 2024-07-08

BIO-OTOTOX

Recruiting

540 enrolled

Ototoxicity

NCT06297369 2024-03-07

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Phase 2 Unknown

60 enrolled

Ototoxicity, Peripheral Nervous System Diseases

NCT05946577 2023-07-14

AURACCO

Not yet recruiting

140 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Head and Neck Neoplasms, Salivary Gland Neoplasms, Tinnitus, Hearing Loss

NCT02890030 2020-04-08

The Platinum Study Comparison Group

Completed

102 enrolled

Genitourinary

Ototoxicity, Testicular Neoplasms, Neurotoxicity Syndromes

NCT01848457 2020-03-16

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Phase 2 Completed

13 enrolled 15 charts

Sarcoma

Ototoxicity, Neoplasms, Osteosarcoma

NCT00652132 2018-05-29

SIOPEL6

Phase 3 Completed

116 enrolled 2 FDA

Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma

NCT03400709 2018-01-17

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Phase NA Completed

45 enrolled

Ototoxicity

NCT02382068 2017-11-09

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Phase NA Withdrawn

Ototoxicity, Neoplasms

Clinical Trials

HEAR

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

OTOPLAT

PROTOTOX

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

RISP-OTOTOX

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer